MedTrace Logo

Cardiac CT's Role in Asymptomatic Patients With Diabetes and Metabolic Syndrome

NCT01564485 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 193

Last updated 2021-06-08

Study results available
· View outcomes & findings →

Summary

This study looked at the role of cardiac CT in improving risk factor control in those with diabetes.

Conditions

Interventions

DIAGNOSTIC_TEST

Cardiac CT

A cardiac CT involves a non-invasive test of the coronary arteries.

BEHAVIORAL

Usual medical care

Patients would be treated by their primary care physicians with usual medical care with drugs such as lipid lowering medication, blood pressure lowering medications, and blood glucose lowering medications. The study will not specify which drugs to use and will it up to the individual physician's discretion.

Sponsors & Collaborators

  • University of California, Irvine

    lead OTHER

Principal Investigators

  • Shaista Malik, MD, PhD · University of California, Irvine

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2016-12-31
Completion
2016-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01564485 on ClinicalTrials.gov